Midomafetamine not checked

Resilient Pharmaceuticals · 3 · 4-methylenedioxymethamphetamine

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
5 active
26 in total · 3 in the EU

What this is

How it works
How it works isn't classified yet
How it’s given
“Midomafetamine HCl is administered orally to study participants.”In the company’s words, NCT07584720 on ClinicalTrials.gov
Tested for
Pharmacokinetics, Hepatic Impairment
Main trialPhase 1
“This Phase 1 study is designed to evaluate the safety and tolerability of midomafetamine in healthy adult participants. The study will also assess how the drug is processed in the body and characterize its effects following administration at two dose levels, including evaluation of cardiac safety using electrocardiographic assessments. This is a single-center, open-label study in which participants will be enrolled into one of two cohorts receiving either a therapeutic dose or a supratherapeutic dose of midomafetamine. Participants will receive study drug in a split dose administration (an…”In the company’s words, NCT07584720 on ClinicalTrials.gov
Other names
3 · 4-methylenedioxymethamphetamine · MDMA · MDMA HCl

Other drugs for Hepatic Impairment

All 20 drugs for Hepatic Impairment

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials26

TrialPhaseCompletesWhat it tests
Phase 1Active, not recruiting 23 Jul 2026 Study of Midomafetamine in Healthy Adults
Phase 1Not yet recruiting Dec 2028 MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
Phase 3Completed 11 Aug 2020 A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Phase 3Completed 30 Oct 2022 A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Phase 3Completed 1 Nov 2023 A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Phase 2Completed 2 May 2008 MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
Phase 2Terminated Mar 2009 Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel
Phase 2Completed 27 Jun 2014 Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
Phase 2Terminated 10 Sep 2015 Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD
Phase 2Completed 3 Dec 2015 Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
Phase 2Completed 25 Apr 2017 MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness
Phase 2Completed 28 Apr 2017 Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults
Phase 2Completed 4 Jun 2019 Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)
Phase 2Completed 10 Aug 2019 Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Phase 2Withdrawn Aug 2023 Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Phase 2Terminated 25 Jun 2024 Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Phase 2Withdrawn Dec 2024 Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
Phase 2Withdrawn 10 Aug 2028 A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
Phase 1/2Completed 16 Dec 2017 MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD
Phase 1Completed 1 Aug 2020 Evaluation of MDMA on Startle Response
Phase 1Completed 5 Aug 2022 Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers
Phase 1Completed 2 Dec 2022 Food Effects on Bioavailability of MDMA in Healthy Volunteers
Phase 1Withdrawn Dec 2025 Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)
Phase 2Authorised not given High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study
Phase 2Authorised not given MDMA-assisted therapy for adolescents with treatment-resistant PTSD
Phase 2Authorised not given A Randomized, Delayed-Treatment Controlled, Phase 2 Pilot Study of Manualized MDMA-Assisted Therapy for Young Adults with Chronic Treatment-Resistant Major Depressive Disorder
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Midomafetamine

Following is part of Solo: you see every change to Midomafetamine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in